Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: tocilizumab

2014 ACR/ARHP Annual Meeting: Macrophage Activation Syndrome

Mary Beth Nierengarten  |  April 1, 2015

The pathogenesis of and new classification criteria for MAS

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:ACR/ARHP Annual Meetingcytokine storm syndromemacrophage activation syndromeNierengartenResearchRheumatic Disease

Can DIY Medicine Tame Rampaging Healthcare Costs?

Simon M. Helfgott, MD  |  April 1, 2015

High health insurance deductibles, physician charges, medication expenses spur patients to seek less costly lab testing, surgical procedures, prescription drugs

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:costsHealth InsuranceHelfgottMedicationprescription drugrheumatologysurgical procedure

Giant Cell Arteritis Challenging to Diagnose, Manage

Sebastian Unizony, MD, and John H. Stone, MD, MPH  |  March 1, 2015

Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets

Filed under:ConditionsResearch RheumVasculitis Tagged with:DiagnosisGiant Cell ArteritisResearchrheumatologyTreatmentVasculitis

2014 ACR/ARHP Annual Meeting: Fibrotic Complications of Scleroderma

Mary Beth Nierengarten  |  February 1, 2015

Rheumatology experts discuss challenge of selecting appropriate SSc patients with skin fibrosis for treatment

Filed under:ConditionsMeeting ReportsSystemic Sclerosis Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)NierengartenSclerodermaTreatment

Biomarkers in Rheumatoid Arthritis Remain Elusive

Kathy Holliman  |  February 1, 2015

Biomarkers to assess disease progression are in use, but none can predict which therapy will work best for each patient

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiomarkersHollimanRheumatoid arthritis

Biomarkers to Guide Diagnosis, Treatment of Rheumatic Diseases

Rick Brasington, MD  |  January 1, 2015

Examining the usefulness, drawbacks of current biomarkers in rheumatology and progress to develop better ones

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiomarkersClinicalDr. Richard Brasington Jr.patient careRheumatic DiseaseRheumatoid arthritis

Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss

Michele B. Kaufman, PharmD, BCGP  |  August 1, 2014

Plus, rheumatology drug news from EULAR 2014

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesEULAR/OtherMeeting ReportsPsoriatic ArthritisRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)Ankylosing Spondylitisanti-inflammatorydrugEULARInternationalKaufmanMethotrexatePsoriatic ArthritisRheumatoid arthritisrheumatologistrheumatologySafetytocilizumabweight loss

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2014

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ActemrabaricitinibbelimumabBiologicsdrugLupusResearchRheumatoid arthritisSafetySystemic lupus erythematosustocilizumabzoledronic acid

What’s New in Inflammatory Arthritis?

Thomas R. Collins  |  June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:AC&RadalimumabAmerican College of Rheumatology (ACR)BiosimilarsCollinsdruginfliximabMethotrexateradiographRheumatoid arthritistocilizumab

Fellow’s Forum Case Report: Takayasu’s Arteritis

Ashwini Komarla, MD; Michael George, MD; Antoine Sreih, MD; & Chris Derk, MD, MS  |  May 1, 2014

How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

Filed under:ConditionsVasculitis Tagged with:drugGiant Cell ArteritisGlucocorticoidsimaginginfliximablarge-vessel vasculitisMethotrexatePainpatient careprednisonerheumatologistrituximabTakayasu’s ArteritistocilizumabTreatmentVasculitis

  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 30
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences